rs377581131
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_144672.4(OTOA):āc.1141C>Gā(p.Gln381Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00203 in 1,614,030 control chromosomes in the GnomAD database, including 78 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0012 ( 5 hom., cov: 32)
Exomes š: 0.0021 ( 73 hom. )
Consequence
OTOA
NM_144672.4 missense
NM_144672.4 missense
Scores
1
6
11
Clinical Significance
Conservation
PhyloP100: 4.07
Genes affected
OTOA (HGNC:16378): (otoancorin) The protein encoded by this gene is specifically expressed in the inner ear, and is located at the interface between the apical surface of the inner ear sensory epithelia and their overlying acellular gels. It is prposed that this protein is involved in the attachment of the inner ear acellular gels to the apical surface of the underlying nonsensory cells. Mutations in this gene are associated with autosomal recessive deafness type 22 (DFNB22). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0036770701).
BP6
Variant 16-21709924-C-G is Benign according to our data. Variant chr16-21709924-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 178846.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-21709924-C-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00119 (181/152220) while in subpopulation SAS AF= 0.0361 (174/4822). AF 95% confidence interval is 0.0317. There are 5 homozygotes in gnomad4. There are 128 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOA | NM_144672.4 | c.1141C>G | p.Gln381Glu | missense_variant | 13/29 | ENST00000646100.2 | NP_653273.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOA | ENST00000646100.2 | c.1141C>G | p.Gln381Glu | missense_variant | 13/29 | NM_144672.4 | ENSP00000496564.2 |
Frequencies
GnomAD3 genomes AF: 0.00120 AC: 183AN: 152102Hom.: 5 Cov.: 32
GnomAD3 genomes
AF:
AC:
183
AN:
152102
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00424 AC: 1066AN: 251360Hom.: 22 AF XY: 0.00584 AC XY: 794AN XY: 135846
GnomAD3 exomes
AF:
AC:
1066
AN:
251360
Hom.:
AF XY:
AC XY:
794
AN XY:
135846
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00211 AC: 3088AN: 1461810Hom.: 73 Cov.: 31 AF XY: 0.00314 AC XY: 2287AN XY: 727212
GnomAD4 exome
AF:
AC:
3088
AN:
1461810
Hom.:
Cov.:
31
AF XY:
AC XY:
2287
AN XY:
727212
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00119 AC: 181AN: 152220Hom.: 5 Cov.: 32 AF XY: 0.00172 AC XY: 128AN XY: 74436
GnomAD4 genome
AF:
AC:
181
AN:
152220
Hom.:
Cov.:
32
AF XY:
AC XY:
128
AN XY:
74436
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
568
Asia WGS
AF:
AC:
43
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 23, 2015 | p.Gln381Glu in exon 12 of OTOA: This variant is not expected to have clinical si gnificance because it has been identified in 3.4% (558/16510) of South Asian chr omosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs377581131). - |
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 19, 2018 | This variant is associated with the following publications: (PMID: 23173898) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Usher syndrome Pathogenic:1
Likely pathogenic, flagged submission | research | SN ONGC Dept of Genetics and Molecular biology Vision Research Foundation | Dec 31, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D;D;D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;M;.;.;.
PrimateAI
Benign
T
PROVEAN
Benign
.;N;N;N;N
REVEL
Benign
Sift
Uncertain
.;D;D;D;D
Sift4G
Pathogenic
.;D;D;D;D
Polyphen
0.87, 0.63
.;P;.;.;P
Vest4
0.36, 0.36, 0.35, 0.43
MutPred
0.23
.;Gain of helix (P = 0.0696);.;.;.;
MVP
0.54
MPC
0.46
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at